$17.55
-0.84 (-4.57%) today
MoonLake Immunotherapeutics (MLTX) is down 53.40% over the past year and 2.61% over the past month, trading at $17.55.
Price · today
Key stats
Market cap$1.29B
Day high$18.26
Day low$17.50
Day open$18.26
Prev close$18.39
ExchangeNASDAQ NMS - GLOBAL MARKET
Performance · all intervals
1D
-4.57%
1W
+2.87%
1M
-2.61%
3M
+11.29%
6M
+37.43%
YTD
+33.16%
1Y
-53.40%
5Y
+75.50%
ALL
+66.19%
Green vs red closes
Last 1D
0up1down
0% green
Last 1W
2up3down
40% green
Last 1M
8up13down
38% green
Last 3M
30up32down
48% green
Last 6M
60up62down
49% green
Year to date
44up47down
48% green
Last 1Y
130up117down
53% green
Last 5Y
608up548down
53% green
Custom Interval
Pick any window — not just the presets above.
days
Related stocks
Compare MLTX with
Latest news on MLTX
Needham Maintains Buy on MoonLake, Raises Price Target to $30
Benzinga·3d ago
FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars
Benzinga·4d ago
HC Wainwright & Co. Maintains Buy on MoonLake, Raises Price Target to $45
Benzinga·4d ago
Reported Sunday, MoonLake Secures FDA Alignment On Sonelokimab BLA Submission Plan, Holds $357.9M Cash With Runway Through End Of 2027
Benzinga·5d ago
MoonLake Immunotherapeutics says U.S. FDA accepts MIRA and VELA-TEEN trial data for sonelkimab BLA submission
Finnhub·5d ago
Reserved